Moxifloxacin Hydrochloride + Dexamethasone  Eye Drops  – ASVIMOX-D is a high-concentration ophthalmic formulation of Asvins Lifecare that is designed to address ocular complex conditions rapidly. ASVIMOX-D is an effective combination of a strong 4th-generation fluoroquinolone and a strong corticosteroid agent, which provides a potent clinical option to address the impact of acute bacterial infections with an influential inflammatory process.

Moxifloxacin Hydrochloride + Dexamethasone  Eye Drops Composition (Each ml contains):

• Moxifloxacin Hydrochloride: 0.5% w/v
• Dexamethasone Sodium Phosphate: 0.1% w/v
• Benzalkonium Chloride Solution (as preservative): 0.2% v/v

Dosage Form: Ophthalmic Solution

Therapeutic Class: Antibiotic and Corticosteroid Combination (Eye Infection and Inflammation Relief)

About Moxifloxacin Hydrochloride + Dexamethasone  Eye Drops

ASVIMOX-D is a potent formulation that is formulated using three well-balanced active ingredients:

1. Moxifloxacin HCl (0.5% w/v): It is a broad-spectrum antibacterial agent that blocks bacterial DNA replication. It has an advanced molecular structure, which enables it to penetrate through the ocular tissues better than previous antibiotic generations.
2. Dexamethasone Sodium Phosphate (0.1% w/v): This is a potent synthetic corticosteroid that inhibits the inflammatory cascade by reducing redness, swelling, and pain by inhibiting the release of arachidonic acid.
3. Benzalkonium Chloride (0.02% v/v): It is a pharmaceutical-grade preservative, which is added to ensure the solution remains sterile across the entire shelf life.

Medical Uses

The Moxifloxacin Hydrochloride + Dexamethasone  Eye Drops combination has mainly been recommended in individuals who are characterised by:

• Post-Surgical Prophylaxis Prevention of endophthalmitis and management of inflammation after cataract, glaucoma, or retinal surgery.
• Severe Bacterial Conjunctivitis: Antimicrobial treatment of infections with the inflammatory process, with major symptoms of patient discomfort or tissue destruction.
• Corneal Injuries: Preventing scarring of non-viral, non-fungal corneal abrasions.
• Anterior Uveitis: Something to reduce the inflammation in the eye, and do this by taking a protective layer of antibiotics over the eye.

Directions to Use

• Shake the container of the eye drop properly, and then invert the bottle and use.
• Bend the head backwards and draw down the lower eyelid, creating a pocket.
• Drop a single drop into the affected eye(s) normally every four to six hours or as per the instructions of your ophthalmologist.
• To avoid systemic absorption, one should apply finger pressure on the lacrimal duct (corner of the eye) one minute after the instillation.
• Limit the use of secondary complications by not going past the acceptable time of therapy.

Precautions

• Diagnostic Accuracy: These must not be a viral or fungal infection (e.g., Herpes Simplex), which may be worsened by steroids.
• Steroid Sensitivity: A chronic intake of steroids has been known to cause elevated pressure in the eyes (IOP) or cataracts in the back of the eyes (SRI, 2017).
• Cross-Contamination: Do not touch the dropper tip to the surface or even the eye.
  Superinfection: Prolonged use of antibiotics can lead to the proliferation of non-susceptible organisms.

Possible Side Effects

Although this is effective, the ASVIMOX-D – Moxifloxacin Hydrochloride + Dexamethasone  Eye Drops side effects can lead to:

• Fleeting eye infection or the feeling of a burning in the eyes.
• Hub of blood hyperemia (blood in the eyes).
• Temporary blurred vision.
• Uncommonly, a sense of dry eye or overflow of tears (tearing).

FAQs

Q: What is the reason ASVIMOX-D has been made with Dexamethasone as opposed to a less strong steroid such as Loteprednol?

A: Dexamethasone is a potent anti-inflammatory agent and was selected in ASVIMOX-D to achieve an immediate effect in the management of severe acute ocular inflammation or trauma.

Q: Should I take ASVIMOX-D in case I have a predisposition to a psychogenic infection?

A: No. Steroids such as Dexamethasone to treat the viruses may deteriorate the situation. This particular medication should never be started without first getting an expert diagnosis.

Q: What is the mechanism by which Asvins Lifecare maintains the stability of the Moxifloxacin and Dexamethasone blend?

A: Asvins Lifecare exploits the pH-buffered stabilization strategy, which helps maintain the active components of the products without degradation so that the effects are consistent.
Intensity even to the very last drop.

Q: Is it possible to use ASVIMOX-D with pediatric patients having inflammatory infections?

A: It is not recommended for children below one year. A pediatric ophthalmologist will be consulted on the specific dosage and safety information for the older children.

Q: Is ASVIMOX-D associated with impairment of the healing process immediately after a corneal scrape?

A: Although it is infection-preventative, the steroid component is capable of slowing down epithelial healing slightly. These factors will be harmonized by your doctor depending on your injury.